Sarepta Therapeutics, Inc. , a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.
Sarepta Therapeutics stock last closed at $127.39, up 2.53% from the previous day, and has increased 3.32% in one year. It has overperformed other stocks in the Biotechnology industry by 0.27 percentage points. Sarepta Therapeutics stock is currently +130.57% from its 52-week low of $55.25, and -20.33% from its 52-week high of $159.89.
There are currently 93.86M SRPT shares outstanding. The market cap of SRPT is $11.96B. In the last 24 hours, 1.52M SRPT shares were traded.
How to Buy Sarepta Therapeutics Stock
Wondering how to invest in Sarepta Therapeutics stock? Here's how.
Decide where to buy Sarepta Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you determine where to buy Sarepta Therapeutics stock.
Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
Deposit funds into your investment account: Pick your method of payment and add your information.
Analyze Sarepta Therapeutics stock: The Sarepta Therapeutics ticker symbol is SRPT. Is Sarepta Therapeutics stock a good investment? Should you buy shares of SRPT? How do SRPT's underlying business fundamentals look? Do top analysts think Sarepta Therapeutics is a good buy? Why has SRPT's stock price moved recently? (Hint: Our stock market analysis tools can help you decide if SRPT is a good stock to buy).
Make your SRPT trade: Decide if you will purchase SRPT shares at the current market price or use a limit order to buy SRPT shares at a given price.
Keep tabs on your SRPT investment: Create a watchlist to the latest updates on your investment in Sarepta Therapeutics shares.
Step 1: Decide where to buy Sarepta Therapeutics stock
You need a brokerage account to access the NASDAQ market and buy SRPT shares.
A brokerage account allows you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
In our opinion, eToro is the best online stock brokerage. eToro gives you:
Invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
Access to world markets: From Tech to Utilities, New York to Shanghai — you can fill your portfolio with stocks from the globe's top exchanges.
Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by signing up for an account with eToro today.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open a brokerage account
Now that you've selected the best brokerage, it's time to fill out some personal information so you are able to invest in SRPT today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Sarepta Therapeutics stock
Once you have figured out the best place to buy Sarepta Therapeutics stock, it's very important to evaluate their stock prior to investing, so you can wrap your head around the risk as well as the opportunity.
Overview of key SRPT info
SRPT Price
$127.39
1w %
9.3%
1y %
3.32%
5y %
5.96%
P/E
-21.96x
P/B
13.91x
P/S
9.47x
PEG
N/A
Revenue
$1.24B
Earnings
-$535.98M
Fore. Rev. Growth
33.92%
Fore. Earn. Growth
N/A
Market Cap
$11.96B
Next Earnings
Jun 6, 2024
Next Dividend
N/A
Sarepta Therapeutics Due Diligence Checks
WallStreetZen was created to help everyday investors perform more in-depth fundamental analysis quickly.
SRPT has $1.68B in cash and short term investments. This is sufficient to cover its annual cash burn of $577.10M.
There are more short-term assets than short-term liabilities on the SRPT balance sheet.
SRPT has cash burn of 577099000. It has enough cash and short-term investments to cover this for at least one year.
There are more short-term assets than long-term liabilities on the SRPT balance sheet.
Failed Financial Due Diligence Checks:
Total SRPT debt is higher than 5 years ago, relative to shareholder equity.
SRPT has a relatively high debt to equity ratio of 2.8.
SRPT profit margin has gone up by 0.32 percentage points in the past year, but the company is still unprofitable.
Is SRPT stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 13 Equities analysts who give forecasts on SRPT, the consensus analyst rating on SRPT is a Strong Buy
Please note that analyst forecasts are not stock recommendations, nor are they investment advice.
Most Recent SRPT Analyst Ratings
Gil Blum, a top 1% analyst from Needham maintains SRPT with a buy rating and lowers their SRPT price target from $169.00 to $166.00, on Feb 29, 2024.
Gavin Clark-Gartner, a bottom 12% analyst from Evercore ISI Group maintains SRPT with a hold rating and raises their SRPT price target from $108.00 to $138.00, on Feb 20, 2024.
Andreas Argyrides, a top 9% analyst from Wedbush reiterates SRPT with a buy rating and maintains their SRPT price target from $224.00 to $224.00, on Feb 20, 2024.
Uy Ear, a bottom 11% analyst from Mizuho maintains SRPT with a strong buy rating and raises their SRPT price target from $130.00 to $145.00, on Feb 14, 2024.
Kostas Biliouris, a bottom 4% analyst from BMO Capital initiates coverage on SRPT with a buy rating and announces their SRPT price target of $170.00, on Jan 31, 2024.
Last year, SRPT revenue was $1.24B. During the last five year, SRPT's revenue has grown by 32.8% per year. This was faster than the Biotechnology industry average of 28.62%.
No, Sarepta Therapeutics doesn't provide an income stream by paying out dividends.
SRPT Social Trading Data
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Make your SRPT trade
You have two main types of orders:
Market order: A market order is an order to buy or sell a security at the best price on the market. Market orders are mostly sufficient.
Limit order: A limit order enables you to buy or sell a security at a specific price (or better). If you want to ensure you're buying or selling at an exact price, place a limit order.
Click the Open Trade button and your broker will execute your order.
If you need more help buying stocks on eToro, watch the helpful video below:
How much does it cost to buy one Sarepta Therapeutics share?
As of Apr 25, 2024, it costs $127.39 to buy one share of Sarepta Therapeutics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.078 shares of SRPT.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.